Your browser doesn't support javascript.
loading
Effect of solvent/detergent-treated pooled plasma on fibrinolysis in reconstituted whole blood.
Saadah, Nicholas H; van der Meer, Pieter F; Brinkman, Herm Jan M; de Korte, Dirk; Bontekoe, Ido J; Korsten, Herbert H; Middelburg, Rutger A; van der Bom, Johanna G; Schipperus, Martin R.
Afiliação
  • Saadah NH; Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands.
  • van der Meer PF; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Brinkman HJM; Center for Clinical Transfusion Research, Sanquin Research, Leiden, the Netherlands.
  • de Korte D; Product and Process Development, Sanquin Blood Bank, Amsterdam, the Netherlands.
  • Bontekoe IJ; Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands.
  • Korsten HH; Product and Process Development, Sanquin Blood Bank, Amsterdam, the Netherlands.
  • Middelburg RA; Department of Blood Cell Research, Sanquin Research, Amsterdam, the Netherlands.
  • van der Bom JG; Product and Process Development, Sanquin Blood Bank, Amsterdam, the Netherlands.
  • Schipperus MR; Product and Process Development, Sanquin Blood Bank, Amsterdam, the Netherlands.
Transfusion ; 57(10): 2381-2389, 2017 10.
Article em En | MEDLINE | ID: mdl-28727139
ABSTRACT

BACKGROUND:

Hyperfibrinolysis has been observed in patients heavily transfused with solvent/detergent-treated pooled plasma (S/D plasma). We compared coagulation and fibrinolytic variables in blood containing S/D plasma with blood containing fresh-frozen plasma (FFP), with and without α2-antiplasmin or tranexamic acid (TXA) supplementation. STUDY DESIGN AND

METHODS:

Whole blood samples were reconstituted from red blood cells, platelet (PLT) concentrates, and varying mixtures of FFP and S/D plasma. Hematocrit and PLT count of reconstituted whole blood samples were varied. For a subset of runs, α2-antiplasmin or TXA was added to S/D plasma whole blood samples. Thromboelastography (TEG) analysis was performed to assess 50% clot lysis time (CLT50% ), maximum amplitude (MA), and initial clotting time (R-time).

RESULTS:

The change in CLT50% of whole blood as the plasma compartment transitions from FFP to S/D plasma was -52% (95% confidence interval [CI], -60% to -45%; p < 0.001). PLT count strengthened the effect, leading to an additional change in CLT50% of -8% (95% CI, -14% to -2%; p = 0.012) as PLT count increased from 10 × 109 to 150 × 109 /L. MA and R-time were not associated with fraction of S/D plasma in whole blood. α2-Antiplasmin and TXA restored clot lysis time in S/D plasma whole blood.

CONCLUSION:

Whole blood with S/D plasma has shorter clot lysis times in vitro compared to whole blood with FFP. α2-Antiplasmin and TXA restore clot lysis time of S/D plasma whole blood to that of FFP whole blood. Clinicians should be aware of the decreased clot lysis time associated with S/D plasma transfusion.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / Solventes / Coagulação Sanguínea / Detergentes / Fibrinólise Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / Solventes / Coagulação Sanguínea / Detergentes / Fibrinólise Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article